Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2662930013 | Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 2674863017 | Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 330841000077116 | Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 615241000077112 | Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable (produit) | fr | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Diphtheria vaccine (substance) | false | Inferred relationship | Some | 5 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Pertussis vaccine (substance) | false | Inferred relationship | Some | 3 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | vaccin inactivé contre la poliomyélite | false | Inferred relationship | Some | 4 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Haemophilus influenzae type b vaccine (substance) | false | Inferred relationship | Some | 1 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Hepatitis B virus recombinant vaccine (substance) | false | Inferred relationship | Some | 6 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Vaccin tétanos | false | Inferred relationship | Some | 2 | |
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | est un(e) (attribut) | Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus + recombinant haemophilus influenzae type B vaccine (product) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Hepatitis B virus recombinant vaccine (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Diphtheria vaccine (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Pertussis vaccine (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Tetanus toxoid (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Haemophilus influenzae type b vaccine (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | vaccin inactivé contre la poliomyélite | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Diphtheria vaccine (substance) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a pour principe actif (attribut) | Vaccin tétanos | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | false | Inferred relationship | Some | ||
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR